The ASTRUM-004 Phase 3 trial delivered promising results for advanced squamous #NSCLC! Adding serplulimab to 1L CT significantly improved survival vs. CT alone.

@cp-cancercell.bsky.social

#Onco404 #Cancer #Kanser #MedSky #OncSky #AkciğerKanseri #Immunotherapy #İmmünoterapi #Serplulimab #ASTRUM004